<SEC-DOCUMENT>0001847903-23-000187.txt : 20231113
<SEC-HEADER>0001847903-23-000187.hdr.sgml : 20231113
<ACCEPTANCE-DATETIME>20231113161706
ACCESSION NUMBER:		0001847903-23-000187
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20231113
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231113
DATE AS OF CHANGE:		20231113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Centessa Pharmaceuticals plc
		CENTRAL INDEX KEY:			0001847903
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40445
		FILM NUMBER:		231399014

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR
		STREET 2:		1 ASHLEY ROAD
		CITY:			ALTRINCHAM, CHESHIRE
		STATE:			X0
		ZIP:			WA14 2DT
		BUSINESS PHONE:		44 7391 789784

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR
		STREET 2:		1 ASHLEY ROAD
		CITY:			ALTRINCHAM, CHESHIRE
		STATE:			X0
		ZIP:			WA14 2DT

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Centessa Pharmaceuticals Ltd
		DATE OF NAME CHANGE:	20210224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cnta-20231113.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:f5c78a84-acc8-48f8-8963-03f0b3114c27,g:548469f0-3b84-4f13-9bf4-b500ba8f4751,d:d5f722243d594afa995b10b8b1c337c0--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cnta="http://www.cnta.com/20231113" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnta-20231113</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-28">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001847903</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnta-20231113.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cnta:AmericanDepositarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id5f722243d594afa995b10b8b1c337c0_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November&#160;13, 2023</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CENTESSA PHARMACEUTICALS PLC</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant, as specified in its charter)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-4">England and Wales</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-40445</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">98-1612294</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mailing address:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3rd Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">1 Ashley Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine3" id="f-9">Altrincham</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Cheshire</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">WA14 2DT</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-12">United Kingdom</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CountryRegion" id="f-13">+44</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">7391</ix:nonNumeric>  <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">789784</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former name or address, if changed since last report:&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-19">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-20">Ordinary shares, nominal value &#163;0.002 per share</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-21">CNTA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-22">Nasdaq Stock Market, LLC</ix:nonNumeric>*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-23">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-24">CNTA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-25">Nasdaq Stock Market, LLC</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Stock Market, LLC.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;</span></div><div><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-26">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="id5f722243d594afa995b10b8b1c337c0_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-30">November&#160;13, 2023</ix:nonNumeric>, Centessa Pharmaceuticals plc (the &#8220;Company&#8221;) announced its financial results for the quarter ended September&#160;30, 2023. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="id5f722243d594afa995b10b8b1c337c0_13"></div><div style="-sec-extract:summary;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="cntapr-q32023.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="cntapr-q32023.htm">November 13</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="cntapr-q32023.htm">, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="id5f722243d594afa995b10b8b1c337c0_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date:&#160;&#160;&#160;&#160;November&#160;13, 2023</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.591%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Saurabh Saha</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saurabh Saha, M.D., Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cntapr-q32023.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia5469ccfdd894943b84848277170b328_1"></div><div style="min-height:94.32pt;width:100%"><div style="margin-bottom:8pt;text-align:center"><img alt="letterhead.jpg" src="letterhead.jpg" style="height:89px;margin-bottom:5pt;vertical-align:text-bottom;width:246px"></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023 </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.15pt">SerpinPC&#58; Ongoing registrational PRESent-2 and PRESent-3 studies for the treatment of hemophilia B&#59; New</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> data from ongoing Phase 2a study </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">accepted for poster presentation</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">at American Society of Hematology (ASH) Annual Meeting in December 2023 </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.15pt">ORX750&#58; Preclinical data supporting potential best-in-class profile for the treatment of narcolepsy and other sleep-wake disorders presented at World Sleep Congress&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%"> Advancing in IND-enabling studies&#59; Clinical proof of concept data planned for 2024</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%;padding-left:14.15pt">LockBody</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%"> Technology Platform&#58; Ongoing Phase 1&#47;2a study of LB101 (PD-L1xCD47)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">for the treatment of solid tumors</font></div><div><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:150%">BOSTON and LONDON, November 13, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Centessa Pharmaceuticals plc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> (Nasdaq&#58; CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today reported financial results and business highlights for the third quarter ended September 30, 2023. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;We continue to execute and achieve key milestones across our pipeline of potential transformative medicines for patients with unmet needs,&#8221; said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. &#8220;We&#8217;re making good progress enrolling our registrational studies for SerpinPC in hemophilia B, with or without inhibitors, and are excited to share new data from the ongoing Phase 2a study of SerpinPC during a poster presentation at ASH in December. We also continue to advance our novel LockBody technology platform with LB101, a PD-L1xCD47 LockBody, which is in an ongoing Phase 1&#47;2a clinical trial for the treatment of solid tumors.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Dr. Saha continued, &#8220;Momentum continues to build with our orexin agonist development program. The preclinical data we recently shared at the World Sleep Congress show that ORX750 is a highly potent and selective novel orexin receptor 2 (OX2R) agonist that closely mimics the function of the endogenous peptide. We believe these data support a potential best-in-class profile for ORX750 for the treatment of narcolepsy and other sleep-wake disorders. We are focused on rapidly moving ORX750 through IND-enabling studies, obtaining IND clearance and initiating clinical development with the goal of sharing clinical proof of concept data in sleep-deprived healthy volunteers in 2024. In addition, we are exploring follow-up molecules for potential expansion opportunities into a range of sleep-wake disorders and broader neurological indications.&#8221;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Recent Highlights</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">In October, the Company a</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">nnounced a set of new preclinical data from</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> in vivo</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">in vitro</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> studies of its investigational, novel OX2R agonist, ORX750, that support a potential best-in-class profile for the treatment of narcolepsy and other sleep-wake disorders. The preclinical data were presented recently at the World Sleep Congress and are also available within a recorded webcast at https&#58;&#47;&#47;investors.centessa.com&#47;events-presentations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">In November, the Company announced that new data from the third year (Part 5) of the ongoing Phase 2a study of SerpinPC, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">an investigational subcutaneously administered novel inhibitor of activated protein C (APC)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">, for the treatment of hemophilia, has been accepted for a poster presentation at ASH on December 10, 2023. The presentation will include efficacy and safety data from an additional 52-weeks of continuous treatment with a subcutaneous injection of SerpinPC in subjects with hemophilia. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">In October, the Company announced the dosing of the first subject in its registrational PRESent-3 clinical study of SerpinPC for the treatment of hemophilia B with inhibitors. T</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">he</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> Company initiated dosing in its registrational PRESent-2 clinical study of SerpinPC for the treatment of hemophilia B without inhibitors in July. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">In August, the Company announced LB206, a PD-L1xCD3 LockBody, as a development candidate and shared preclinical data which demonstrated single agent regressions of large tumors in a difficult-to-treat mouse xenograft model. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Anticipated Upcoming Program Milestones </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:14.15pt">Hemophilia (SerpinPC) -</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> The registrational PRESent-2 and PRESent-3 studies are ongoing. Data from Part 5 of the ongoing Phase 2a study accepted for poster presentation at ASH on December 10, 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:14.15pt">Solid Tumors (LockBody Technology Platform)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:14.11pt">PD-L1xCD47 LockBody LB101</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> - Phase 1&#47;2a first-in-human clinical study is ongoing. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:14.11pt">PD-L1xCD3 LockBody LB206 - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">LB206 is a development candidate. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:14.15pt">Narcolepsy and Other Sleep-Wake Disorders (ORX750) -</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> The Company is focused on rapidly advancing ORX750 through IND-enabling studies, obtaining IND clearance and initiating clinical development with the goal of sharing clinical proof of concept data in sleep-deprived healthy volunteers in 2024. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Where applicable, the Company plans to provide updates on preclinical programs as they advance toward clinical studies.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%"> </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Third Quarter 2023 Financial Results</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:14.15pt">Cash, Cash Equivalents and Short-term Investments&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">$281.3 million as of September 30, 2023, which t</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">he Company expects will fund operations into 2026, without drawing on the remaining available tranches under the Oberland credit facility. </font></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:12.53pt">Research &#38; Development Expenses&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> $28.2 million for the third quarter ended </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">September </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">30, 2023, compared to $36.7 million for the third quarter ended September 30, 2022.</font></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:12.53pt">General &#38; Administrative Expenses</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#58; $12.0 million for the third quarter ended September 30, 2023, compared to $12.3 million for the third quarter ended September 30, 2022.</font></div><div style="margin-bottom:0.08pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%;padding-left:12.53pt">Net Loss Attributable to Ordinary Shareholders&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> $38.6 million for the third quarter ended September 30, 2023, compared to $53.9 million for the third quarter ended September 30, 2022. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">About Centessa Pharmaceuticals </font></div><div style="margin-bottom:0.08pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Centessa Pharmaceuticals plc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit http&#58;&#47;&#47;www.centessa.com&#47;, which does not form part of this release. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">About SerpinPC  </font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">SerpinPC is a subcutaneously administered novel inhibitor of APC being developed as a potential treatment for hemophilia, regardless of severity or inhibitor status, and which may also be developed to prevent bleeding associated with other bleeding disorders. The ongoing registrational program for SerpinPC in hemophilia B includes a set of clinical studies with multiple components. PRESent-5 is an observational feeder study to collect prospective observational data for minimum defined periods before switching to dosing subjects in the interventional studies. The interventional studies include PRESent-2 (moderately severe to severe hemophilia B without inhibitors, and severe hemophilia A with or without inhibitors) and PRESent-3 (hemophilia B with inhibitors). Additional information on the trials can be accessed at www.clinicaltrials.gov (</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">NCT05605678</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">NCT05789524</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">NCT05789537</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">). </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SerpinPC for the treatment of hemophilia B, with or without inhibitors. SerpinPC is an investigational agent that has not been approved by the FDA or any other regulatory authority. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">About the LockBody Technology Platform and LB101 </font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Centessa&#8217;s proprietary LockBody technology platform aims to redefine immuno-oncology treatment for patients with cancer. LockBody drug candidates are designed to selectively drive potent effector function activity, such as CD47 or CD3, to the tumor micro-environment (TME) while avoiding systemic toxicity. The first LockBody candidate is LB101, a conditionally tetravalent PD-L1xCD47 bispecific monoclonal antibody which has two anti-CD47 domains blocked by two anti-PD-L1 domains, with proprietary human IgG-derived hinges linking the anti-CD47 and anti-PD-L1 domains. The cell-killing mechanism of action, CD47, is designed to be blocked by the PD-L1 tumor targeting domain until the IgG-derived hinges are naturally degraded in the TME, thus unlocking and activating the CD47 effector function activity in the tumor. LB101 is in a Phase 1&#47;2a clinical trial. Additional information on the trial can be accessed at www.clinicaltrials.gov (</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">NCT05821777</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">). LB101 is an investigational agent that has not been approved by the FDA or any other regulatory authority.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">About ORX750</font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">ORX750 is an investigational, orally administered, highly potent and selective orexin receptor 2 (OX2R) agonist designed to directly target the underlying pathophysiology of orexin neuron loss in narcolepsy type 1 (NT1). ORX750 is Centessa&#8217;s first orexin product candidate being developed for the treatment of narcolepsy with potential expansion into other sleep-wake disorders. ORX750 is currently undergoing IND-enabling activities and has not been administered as an investigational drug to humans in any jurisdiction.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:150%">Forward Looking Statements  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">This press release contains forward-looking statements. These statements may be identified by words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;objective,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;ongoing,&#8221; &#8220;aim,&#8221; &#8220;seek,&#8221; and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including statements related to the Company&#8217;s ability to discover and develop transformational medicines for patients&#59; its expectations for executing on the Company's pipeline&#59; its expectations on its anticipated cash runway &#59; the timing of commencement of new studies or clinical trials or clinical and preclinical data related to SerpinPC, LB101, LB206, other LockBody candidates, the LockBody technology platform, ORX750 and other orexin agonist molecules&#59; its ability to identify, </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">screen, recruit and maintain a sufficient number of or any subjects in its existing and anticipated studies or clinical trials including PRESent-5, the observational feeder study, PRESent-2 and PRESent-3 and studies or trials of LB101, LB206, and any other LockBody candidates, ORX750 and other orexin agonist molecules and its expectations on executing its research and clinical development plans and the timing thereof&#59; the Company&#8217;s ability to differentiate SerpinPC, LB101, LB206, ORX750, other orexin agonist molecules, and other LockBody candidates from other treatment options&#59; the development and therapeutic potential of SerpinPC, LB101, LB206, other LockBody candidates, the LockBody technology platform, ORX750 and other orexin agonist molecules&#59; and regulatory matters, including the timing and likelihood of success of obtaining authorizations to initiate or continue clinical trials. Any forward-looking statements in this press release are based on our current expectations, estimates, assumptions and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the safety and tolerability profile of our product candidates&#59; our ability to identify, screen and recruit a sufficient number of or any subjects in our existing and anticipated new studies or clinical trials including PRESent-2, PRESent-3, PRESent-5, and studies or trials of LB101 or within anticipated timelines&#59; our ability to execute IND-enabling activities in a timely manner or at all, including with respect to ORX750 and LB206&#59; our ability to protect and maintain our intellectual property position&#59; business (including commercial viability), regulatory, economic and competitive risks, uncertainties, contingencies and assumptions about the Company&#59; risks inherent in developing product candidates and technologies&#59; future results from our ongoing and planned clinical trials&#59; our ability to obtain adequate financing, including through our financing facility with Oberland, to fund our planned clinical trials and other expenses&#59; trends in the industry&#59; the legal and regulatory framework for the industry, including the receipt and maintenance of clearances to conduct or continue clinical testing&#59; our operating costs and use of cash, including cash runway, cost of development activities and conducting clinical trials, future expenditures risks&#59; the risk that any one or more of our product candidates will not be successfully developed and&#47;or commercialized&#59; the risk that the historical results of preclinical studies or clinical studies will not be predictive of future results in ongoing or future studies&#59; economic risks to the United States and United Kingdom banking systems&#59; and geo-political risks such as the Russia-Ukraine war or the Israeli-Palestinian conflict. These and other risks concerning our programs and operations are described in additional detail in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and our other reports, which are on file with the </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">U.S. Securities and Exchange Commission (SEC). We explicitly disclaim any obligation to update any forward-looking statements except to the extent required by law. </font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Contact&#58;</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Kristen K. Sheppard, Esq.</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">SVP of Investor Relations</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">investors&#64;centessa.com</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Centessa Pharmaceuticals plc</font></div><div style="margin-bottom:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations and Comprehensive Loss</font></div><div style="margin-bottom:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(amounts in thousands except share and per share data)</font></div><div style="margin-bottom:0.05pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended<br>September 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended<br>September 30, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Nine Months Ended<br>September 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Nine Months Ended<br>September 30, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">28,190&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">36,744&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94,689&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">127,248&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and administrative</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,019&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,284&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,416&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,432&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Change in fair value of contingent value rights</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,980&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from operations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(40,209)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(49,028)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(136,105)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(170,660)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,953&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">77&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,543&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">205&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,541)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,922)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(7,336)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(5,074)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other (expense) income, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,677)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(3,143)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4,550)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,412&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss before income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(41,474)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(54,016)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(140,448)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(173,117)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Income tax (benefit) expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,826)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(141)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(26,200)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(83)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(38,648)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(53,875)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(114,248)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(173,034)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other comprehensive income (loss)&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Foreign currency translation adjustment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(419)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(553)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,241&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,383)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Unrealized gain on available for sale securities, net of tax</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">252&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,035&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other comprehensive income (loss)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(167)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(553)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,276&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,383)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total comprehensive loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(38,815)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(54,428)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(111,972)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(175,417)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss per ordinary share - basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.40)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.57)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1.20)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1.86)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted average ordinary shares outstanding - basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">96,648,110&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94,327,914&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">95,589,181&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">92,994,990&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:0.05pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Centessa Pharmaceuticals plc</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="margin-bottom:2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(amounts in thousands)</font></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">September 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">171,498&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">393,644&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Short-term investments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">109,843&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">96,023&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">50,663&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">377,364&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">444,307&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">43,974&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38,338&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Long term debt</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">74,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">69,800&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">117,974&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">108,138&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total shareholders&#8217; equity</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">259,390&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">336,169&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities and shareholders' equity</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">377,364&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">444,307&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cnta-20231113.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f5c78a84-acc8-48f8-8963-03f0b3114c27,g:548469f0-3b84-4f13-9bf4-b500ba8f4751-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnta="http://www.cnta.com/20231113" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cnta.com/20231113">
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20231113_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20231113_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20231113_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cnta.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cnta_AmericanDepositarySharesMember" abstract="true" name="AmericanDepositarySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cnta-20231113_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f5c78a84-acc8-48f8-8963-03f0b3114c27,g:548469f0-3b84-4f13-9bf4-b500ba8f4751-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cnta.com/role/Cover" xlink:type="simple" xlink:href="cnta-20231113.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.cnta.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_918e5b8f-2848-4122-b697-aea86cae9e12" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_DocumentType_918e5b8f-2848-4122-b697-aea86cae9e12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5ff1e6b8-60bc-4537-bfd3-62e86da9c5e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_DocumentPeriodEndDate_5ff1e6b8-60bc-4537-bfd3-62e86da9c5e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a43931bc-4e93-4d31-9de6-65b1fa799b2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityRegistrantName_a43931bc-4e93-4d31-9de6-65b1fa799b2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_22d8fdda-ffb2-4a1f-beba-5806f10bf231" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityIncorporationStateCountryCode_22d8fdda-ffb2-4a1f-beba-5806f10bf231" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_82f59cf6-e4c4-4fbd-9f1c-11115ef830eb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityFileNumber_82f59cf6-e4c4-4fbd-9f1c-11115ef830eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3ab267a0-5bea-497b-8295-c880fa5802e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressAddressLine1_3ab267a0-5bea-497b-8295-c880fa5802e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_a0ab668e-9a2c-4e8d-a7bb-f9b3cc726a2c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressAddressLine2_a0ab668e-9a2c-4e8d-a7bb-f9b3cc726a2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_4c8f9d4a-4398-4ec9-8930-78c492421ac9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressAddressLine3_4c8f9d4a-4398-4ec9-8930-78c492421ac9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_30a25c19-43ff-48cc-9025-f5c6c3567a7e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressCityOrTown_30a25c19-43ff-48cc-9025-f5c6c3567a7e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c6539556-f91a-46b9-8c3d-b174dfd202d7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressPostalZipCode_c6539556-f91a-46b9-8c3d-b174dfd202d7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_685224e5-39d4-42c4-bae0-587482d8b710" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressCountry_685224e5-39d4-42c4-bae0-587482d8b710" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_bed70bce-7188-4629-8185-442f26a5943a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_CountryRegion_bed70bce-7188-4629-8185-442f26a5943a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d37a131e-e664-4ba8-af76-85db207d96a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_CityAreaCode_d37a131e-e664-4ba8-af76-85db207d96a5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_167b3274-deaf-43cd-8835-58343028bf2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_LocalPhoneNumber_167b3274-deaf-43cd-8835-58343028bf2a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_8c147dc2-d4a7-4b39-b125-cb3f28769dda" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_WrittenCommunications_8c147dc2-d4a7-4b39-b125-cb3f28769dda" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_60adeb42-1121-449d-be04-6f28024f553a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_SolicitingMaterial_60adeb42-1121-449d-be04-6f28024f553a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_3160119a-1425-4951-a5a4-99e48c86278a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_PreCommencementTenderOffer_3160119a-1425-4951-a5a4-99e48c86278a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e07b7dbe-8f43-4cbe-81b5-3f3a8c54b1e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e07b7dbe-8f43-4cbe-81b5-3f3a8c54b1e8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1455f71d-d315-4a1d-b517-bc12945fb8ec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_Security12bTitle_1455f71d-d315-4a1d-b517-bc12945fb8ec" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_19b46743-85cf-40d3-b006-923de98ae784" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_TradingSymbol_19b46743-85cf-40d3-b006-923de98ae784" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fafb2d00-8a70-4668-9cd6-6acefa635534" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_SecurityExchangeName_fafb2d00-8a70-4668-9cd6-6acefa635534" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e5043ba8-0ebb-4aba-a0fc-f8dd405c7e0e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityEmergingGrowthCompany_e5043ba8-0ebb-4aba-a0fc-f8dd405c7e0e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_4420c205-0a25-466e-b8b3-f2cddf9b0078" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityExTransitionPeriod_4420c205-0a25-466e-b8b3-f2cddf9b0078" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5847ec91-1521-423d-9a46-47e8825ae2a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_AmendmentFlag_5847ec91-1521-423d-9a46-47e8825ae2a4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_baf0c2b8-b399-453a-93a0-17d5450ecd4d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityCentralIndexKey_baf0c2b8-b399-453a-93a0-17d5450ecd4d" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_23cce1e3-a0cb-4591-ae9d-5c8bc6cab2c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_DocumentInformationTable_23cce1e3-a0cb-4591-ae9d-5c8bc6cab2c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ac3f2d66-7bc1-44d3-ac8e-98c101026e10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_23cce1e3-a0cb-4591-ae9d-5c8bc6cab2c7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ac3f2d66-7bc1-44d3-ac8e-98c101026e10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ac3f2d66-7bc1-44d3-ac8e-98c101026e10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ac3f2d66-7bc1-44d3-ac8e-98c101026e10" xlink:to="loc_us-gaap_ClassOfStockDomain_ac3f2d66-7bc1-44d3-ac8e-98c101026e10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ac3f2d66-7bc1-44d3-ac8e-98c101026e10" xlink:to="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c70b4914-1e01-4e5f-aca9-aed9ab74a883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:to="loc_us-gaap_CommonStockMember_c70b4914-1e01-4e5f-aca9-aed9ab74a883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember_49384078-9284-402d-9594-6abd2a9e7eca" xlink:href="cnta-20231113.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:to="loc_cnta_AmericanDepositarySharesMember_49384078-9284-402d-9594-6abd2a9e7eca" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cnta-20231113_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f5c78a84-acc8-48f8-8963-03f0b3114c27,g:548469f0-3b84-4f13-9bf4-b500ba8f4751-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressCountry_3f084734-6f9c-4606-86e2-33885c94b4eb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_51ddcc20-f4e5-48f3-87dc-c6a8880f8a53_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_cf7e1d64-1b6a-4574-adc9-d4fb707a0077_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ea41c699-2ef7-45b6-a0b5-def0a5ecdc7b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_9a8b37fb-98a9-4e33-9902-45a724f4ed2b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_d64779fc-b9dc-424c-94fb-f6ac1f909aba_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3ace8103-dc70-4ad6-bf40-37ce5898ed8a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9e1fef91-6e59-4166-8e3c-a43b6d70bb48_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_65cb71cf-1978-48ee-bfb1-c94b4370ed78_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_373c65d9-b3f2-47bd-9208-0f64633d391d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_bf370750-8634-4428-9af0-22ab5affbaad_terseLabel_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares</link:label>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_label_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_documentation_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember" xlink:href="cnta-20231113.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnta_AmericanDepositarySharesMember" xlink:to="lab_cnta_AmericanDepositarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_fe0b8598-050e-445f-865e-77d80b2bb9c6_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7c256eaf-a58b-4059-a7e2-cd8235e07bc0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_455218f9-a025-4bfc-b8a8-55b399a9bf61_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_13a7fcad-295e-45f7-982f-d626f647bc88_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_1f3e9e04-a3bf-4397-8bc9-e5437787ed33_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3e10acf6-92d1-4bf2-98d1-7c39d526e025_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_477e98b4-8ce6-4378-abbe-489701d988fb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b8c7b34a-90b7-4215-9455-1d5e77c558c3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_505b3b82-c89e-4c1a-9d29-fa5e9899cef6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bb194d1e-b074-496f-bc8e-a6591ef8e009_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_db1ba1ec-2955-4471-ac39-6343af13c421_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_50cd4e35-aac1-4f5c-af95-68c0720bb5e0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_d397f441-543b-4182-a542-dc6d6591e93e_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_c68a8a4a-ab18-411e-b89e-918f932e2a28_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_5b3dafef-f8e7-4fe6-ab10-f3dda615e5c5_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_21e17048-0f60-4b8d-a366-6742fd43a68b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_dda590ac-1b3a-4ec4-9c4c-be15e6ed45d2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c872c135-3f13-4f1e-9382-f92108664442_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_2ee23f51-1cb4-439a-a6c4-3d9b1eceb411_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine3_098e3292-2cd0-46ec-be46-0770bee75772_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine3_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3" xlink:to="lab_dei_EntityAddressAddressLine3" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_77c76ede-094e-40c5-b1f9-b78b50c5cd21_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cnta-20231113_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f5c78a84-acc8-48f8-8963-03f0b3114c27,g:548469f0-3b84-4f13-9bf4-b500ba8f4751-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cnta.com/role/Cover" xlink:type="simple" xlink:href="cnta-20231113.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cnta.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b554d881-4e8f-45ed-98c0-37210e85f895" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_23cce1e3-a0cb-4591-ae9d-5c8bc6cab2c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b554d881-4e8f-45ed-98c0-37210e85f895" xlink:to="loc_dei_DocumentInformationTable_23cce1e3-a0cb-4591-ae9d-5c8bc6cab2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ac3f2d66-7bc1-44d3-ac8e-98c101026e10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_23cce1e3-a0cb-4591-ae9d-5c8bc6cab2c7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ac3f2d66-7bc1-44d3-ac8e-98c101026e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ac3f2d66-7bc1-44d3-ac8e-98c101026e10" xlink:to="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c70b4914-1e01-4e5f-aca9-aed9ab74a883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:to="loc_us-gaap_CommonStockMember_c70b4914-1e01-4e5f-aca9-aed9ab74a883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember_49384078-9284-402d-9594-6abd2a9e7eca" xlink:href="cnta-20231113.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_65008f32-0fcc-43f7-9b44-30944785cbaf" xlink:to="loc_cnta_AmericanDepositarySharesMember_49384078-9284-402d-9594-6abd2a9e7eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_23cce1e3-a0cb-4591-ae9d-5c8bc6cab2c7" xlink:to="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_918e5b8f-2848-4122-b697-aea86cae9e12" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_DocumentType_918e5b8f-2848-4122-b697-aea86cae9e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5ff1e6b8-60bc-4537-bfd3-62e86da9c5e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_DocumentPeriodEndDate_5ff1e6b8-60bc-4537-bfd3-62e86da9c5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a43931bc-4e93-4d31-9de6-65b1fa799b2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityRegistrantName_a43931bc-4e93-4d31-9de6-65b1fa799b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_22d8fdda-ffb2-4a1f-beba-5806f10bf231" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityIncorporationStateCountryCode_22d8fdda-ffb2-4a1f-beba-5806f10bf231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_82f59cf6-e4c4-4fbd-9f1c-11115ef830eb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityFileNumber_82f59cf6-e4c4-4fbd-9f1c-11115ef830eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3ab267a0-5bea-497b-8295-c880fa5802e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressAddressLine1_3ab267a0-5bea-497b-8295-c880fa5802e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_a0ab668e-9a2c-4e8d-a7bb-f9b3cc726a2c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressAddressLine2_a0ab668e-9a2c-4e8d-a7bb-f9b3cc726a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_4c8f9d4a-4398-4ec9-8930-78c492421ac9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressAddressLine3_4c8f9d4a-4398-4ec9-8930-78c492421ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_30a25c19-43ff-48cc-9025-f5c6c3567a7e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressCityOrTown_30a25c19-43ff-48cc-9025-f5c6c3567a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c6539556-f91a-46b9-8c3d-b174dfd202d7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressPostalZipCode_c6539556-f91a-46b9-8c3d-b174dfd202d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_685224e5-39d4-42c4-bae0-587482d8b710" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityAddressCountry_685224e5-39d4-42c4-bae0-587482d8b710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_bed70bce-7188-4629-8185-442f26a5943a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_CountryRegion_bed70bce-7188-4629-8185-442f26a5943a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d37a131e-e664-4ba8-af76-85db207d96a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_CityAreaCode_d37a131e-e664-4ba8-af76-85db207d96a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_167b3274-deaf-43cd-8835-58343028bf2a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_LocalPhoneNumber_167b3274-deaf-43cd-8835-58343028bf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_8c147dc2-d4a7-4b39-b125-cb3f28769dda" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_WrittenCommunications_8c147dc2-d4a7-4b39-b125-cb3f28769dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_60adeb42-1121-449d-be04-6f28024f553a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_SolicitingMaterial_60adeb42-1121-449d-be04-6f28024f553a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_3160119a-1425-4951-a5a4-99e48c86278a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_PreCommencementTenderOffer_3160119a-1425-4951-a5a4-99e48c86278a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e07b7dbe-8f43-4cbe-81b5-3f3a8c54b1e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e07b7dbe-8f43-4cbe-81b5-3f3a8c54b1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1455f71d-d315-4a1d-b517-bc12945fb8ec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_Security12bTitle_1455f71d-d315-4a1d-b517-bc12945fb8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_19b46743-85cf-40d3-b006-923de98ae784" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_TradingSymbol_19b46743-85cf-40d3-b006-923de98ae784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fafb2d00-8a70-4668-9cd6-6acefa635534" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_SecurityExchangeName_fafb2d00-8a70-4668-9cd6-6acefa635534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e5043ba8-0ebb-4aba-a0fc-f8dd405c7e0e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityEmergingGrowthCompany_e5043ba8-0ebb-4aba-a0fc-f8dd405c7e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_4420c205-0a25-466e-b8b3-f2cddf9b0078" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityExTransitionPeriod_4420c205-0a25-466e-b8b3-f2cddf9b0078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5847ec91-1521-423d-9a46-47e8825ae2a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_AmendmentFlag_5847ec91-1521-423d-9a46-47e8825ae2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_baf0c2b8-b399-453a-93a0-17d5450ecd4d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_b89cb850-9b0a-4a49-8d78-1587ed2fbb65" xlink:to="loc_dei_EntityCentralIndexKey_baf0c2b8-b399-453a-93a0-17d5450ecd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3b259fc2-849c-4af0-8380-eb142cf23fd1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b554d881-4e8f-45ed-98c0-37210e85f895" xlink:to="loc_dei_EntityTaxIdentificationNumber_3b259fc2-849c-4af0-8380-eb142cf23fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>letterhead.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 letterhead.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (>!=P# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^9^VY#GT,TA[*KI57X^:_5?H=]1117@'UX4444 %%%% !117@7[47[4>G?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOTZ_X0/PU_T+ND_^ ,7_ ,31_P ('X:_Z%W2?_ &+_XFODO[7P7_ $"K\/\
M(_0_]7<S_P"@^7_DW_R1^8I_;-^,@Z^+Y1_VXVW_ ,:IO_#:'QB_Z'&3_P
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M"WAD@+P1HREF8'E%&> .M>;_ +6/[&=KX$TB[\9^!TD_L> [[_268N;92?\
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MQKZ]KR,ZS&56H\-2?NK?S?\ DCZ/A?)84*,<=75YRU7DN_J_R^84445\H?H
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MO]> ?L*_\FWZ!_U\W?\ Z/>O?Z_*\P_WNK_B?YG[[E'_ "+L/_@C^2"BBBN
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M_P#OE'_%'\T?K91117X\?TB%%%% !1110 4444 ?D#^TA_R7GQ[_ -AFZ_\
M1C5YO7I'[2'_ "7GQ[_V&;K_ -&-7F]?L>'_ (,/1?D?S7C/]YJ_XI?FS[E_
M9<_:O^'WPK^#.D^'=?O;R'4[>:X>1(;1G4!Y69<$=>"*]9_X;T^$O_01U'_P
M >OE;X*_L3ZG\9OA[8>*[;Q1::;%=22QBVEM7=EV.4Z@CKC/XUW7_#M36_\
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M[LUN^#CN".C ]P00:]D^._['/B[X/M<:E9(WB/PRN6^WVL9\R!<_\MH^2O\
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MBK<THNWR1^EE%%%?F9^YA1110 4444 %?-_[?G_)OT__ &$K?_V>OI"OF_\
M;]('[/TV3UU.WQ^3UZ66_P"^4O\ $CQ<Z_Y%N(_PO\C\R:]:_91_Y.(\#_\
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M_P!#/+_X+KG_ .-U^;_4,7_SZE]S/VQ9OE[5_K$/_ E_F>[T5X1_PV]\'?\
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M1M%(R.I5U."I&"#7TQ_P3W_Y+Y)_V"+C_P!"CK[#,O\ <ZOHS\VR7_D94/\
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MM;'<,'R(QM5L=MQRV.VZN&\(^%M1\;>)M-T+2;=KG4;^=8(8U[L3U/H!U)[
M$T>%O"6L^-M:M])T+3;C5-1G.([>W0LQ]2?0#N3P.]?I)^RI^RE;?!&S.NZX
M8;[QA=1["R?-'8H>L:'NQ_B;\!QDM]OB\71RN@H+=*R1^69?EV)SW%NI+X6[
MRETUU:7GV1[1\.?!=K\.O NA^&K,[X--M4@\S&/,8#YWQZLQ9OQKHZ**_+Y2
M<Y.4MV?O%.$:<%""LEHBEK7_ "!K_P#Z]Y/_ $$U\ _\$^?C!:^%?%FI>"M3
MG6"VUPI+9.YPHNE&-GU=3@>Z*.]??NN,%T74"3@"WD)/_ 37XEQS26\R21NT
M<J$,K*<%2.X-?59+AXXO#UZ,NMOU/@.)L;/+\7A,33U<>;3NO=NON/W"HK\_
MO@I_P4$U+PY9V^D^/K&;7+:(!$U6T(%T%X'[Q6(63ZY4^NXU]1^&?VM/A/XI
M@1X/&-E8NW!BU(-:LI]"7 4_@37D8C*\5AI6E!M=UJOZ]3Z+!Y]E^-BG&HHO
MM+1_CO\ *YZ]17&#XT?#\Q[QXX\.;<9S_:L'_P 77/ZY^U%\*?#T4CW/CC2I
MMG5;&0W3'V B#5Q1P]:3M&#?R9ZDL9AJ:O.K%+U1ZG7QQ_P4.^+=KI_A6P\
M64ZR:A?RI>7Z*<^5"AS&K>A9\-]$]Q5#XM?\%$K&&SGL?A_I4T]VP*C5=30*
MD?\ M)%DECZ;B/<&OA_7M?U+Q5K5WJVK7DVH:E=R&6>XG;<[L>Y/^< 5]7E.
M458U5B,0K);+K?\ 0_/^(.(\/4H2PF#ES.6C?1+JEWO]UC/K]!O^">OPBG\.
M^%]3\<ZC 8KC6 +6P5Q@BV5LN_T=P,?]<\]#7CO[,O[&6K_$:]M/$/B^VFTC
MPJC"1+>0%)[\#D!1U5#W;N/N]<C]&[&RM]-LX+2TACMK6WC6**&)0J(BC"J
M.@  &*USO,H.#PM)W;W_ ,CGX6R6HJJQ^(C9+X4^M^OIV[[D]%%4M9UFQ\/:
M5=ZGJ=U%8Z?:QM-/<3-M2- ,DDU\0DV[(_4VU%7>Q\V?M\?%@>"_A='X7LYM
MNJ>(F,;A3REJA!D/_ CM7W!?TK\X+&SFU&\@M;>-IIYG6..-!DLQ. ![DUZ)
M^T1\79OC3\4=4\0?.FG _9M/A?K';H2%X[$Y+$>K&F_LW-IJ?';P0VKO''9+
MJD+%I2 H<-F/.>V_;7ZA@,/_ &?@]5[UFWZ]OT/P;-L9_;&9:/W+J*]+VO\
M/<_4WX0^ 8/A?\-?#_AF$+NL+55F9!P\Q^:5OQ<L?QKL***_,9SE4DYRW9^[
M4Z<:,(TX*R2LO1!1114&@4444 %<[\0_!MK\0O ^N>&[S'D:E:26^XC.QB/E
M?ZJV&_"NBHJHR<)*4=T1.$:D7":NGHS\1=8TJYT+5KW3;R/RKNSF>WFC_NNK
M%6'X$&JJL48,."#FO4OVI)-/F_:!\;OI;QRVC:@Q+1G*F3:/-_\ (F^O*Z_8
MZ,W4IQFU:Z3^\_FK$4E1K3I)WY6U]SL?KO\ LU_$P?%?X-^']:DE\S4(XOL=
M]SS]HC 5B?\ >&U_^!BO3Z_.']@WXWVWP_\ &MWX4UFZ6VT?7BOD32MA(;L<
M+D]@X.W/J$K]'J_,,TPKPF)E%+W7JO3_ (&Q^[Y%F"S# PFW[T=)>JZ_/<**
M**\D^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBO%?VAOVAK/X3Z:^F:8\=WXHN$_=Q?>6U4CB1QZ^B_B>.O5AL-5Q=54:*NV>
M?CL=A\MP\L3B96BOQ\EW;%_:&_:&L_A/IKZ9IC1W?BBX3]W%PRVJD<2./7T7
MOU/'7X&U;5KS7M2N-0U"XDN[RX<R2S2L69F)R231JVK7FNZE<7]_<27=Y<.9
M)9I6+,S$Y))JG7ZYEN6TLNI<L=9/=]_^ ?S-GV?8C/,1SST@OACV\WW;ZL**
M*?##)<3)%$C22.=JJHR23VKUSY@(HGFD6.-2[L<*JC))K[6_9H_9G3PC';>*
M?%-L'UM@)+2QD&1:#L[#_GIZ#^'Z_=7]FG]F=/",=MXI\4VX?6V DM+&09%H
M.SL/^>GH/X?K]WZ4K\\SO._:7PN%>G5]_)>7=]?3?]PX3X3]CRYAF$?>WC%]
M/-^?9=-WKL5G>(?$.F^$]%O-7U>\BT_3;.,RSW$S85%'\SV ')) '-'B+Q%I
MOA/1+S5]7O(M/TVSC,L]Q,V%11_,]@!R20!S7YB?M0?M0:E\=-:.GZ>9=/\
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MSRDJ=T8=P?\  C! -??7PM^*6D_%3PZFH:>_E7,>%NK-FR\#_P!5/.&[^Q!
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MHH_M[&]U]P?ZI99VE]Y^</\ P[I^)'_04\._^!4W_P 9H_X=T_$C_H*>'?\
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MA$!_X\17Z>T5[$<_QD=[/Y?Y6/FZG".6S?N\T?1_YIGY9?\ #$/QC_Z%A/\
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M#\.8/"3]I0E*+\I/7U[H****\0^I"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***P/'3>(5\*W_P#PBJ6KZZ4Q;_;&VH">IZ$%@,X!XSC/
M%7"//)1O:_?8RJU/90E.S=E>RU;]%W/-/VAOVAK/X3Z:^F:8\=WXHN$_=Q\,
MMJI'$CCU]%_$\=?@;5M6O-<U*XO[^XDN[RX<R2S2L69F)R2375>/_ ?C?1]8
MN[OQ1I.HK=S.9);NX1G61B>3Y@RK?@:XS:<XQS7[!E6 H8*C^Z:DWO+O_P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+E(5_NC^\YYPOXG !-?J=\/OA]H?PP\*V?A_P]9K9Z?;#ZO*Y^]([?Q,>Y_
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MYEQ]X5K3ISK34*:NV85J]/#TW5K2Y8K=L]*HKYA_X>&_"_\ Y]/$/_@'%_\
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MC'=D3G&G%SF[):LWJ*^8?^'AOPO_ .?3Q#_X!Q?_ !VC_AX;\+_^?3Q#_P"
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MKA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMS!ILKLL-M&PRF\ @LY!!(/ SC&1FO(O^"@5O+;_ +0%I-<HS6\FE6S1\<%
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MX[?\GY:?_P!AO1_Y6]?H]7YP?'!A<?MZ6*Q?O&77-(!"]B!;YHR/^-4_P/\
M0.*?]VH?]?(_DS]'Z***^=/LPHHHH \AU7]DKX3:WJEYJ-[X0BGO+R9[B>4W
MER-\CL69L"3 R2>E?#GB/X9^&;+]LR'P7!I:IX9;6;6U-AYLA'ENL99=V[=S
MN/?/-?J#7YR^+?\ E(1!_P!C#9?^@Q5]5E&(K5)55.;=H.VK\C\_XCP>&I1P
M\J=**;J13LDKK7<^M8?V/?@_;S)+'X,A61"&4_;;DX(_[:U[+117S=2M5K6]
MI)RMW=S[>CA:&&O["FHWWLDOR"BBBL3I"OA'_@I9_P AKP!_UQO/_0HJ^[J^
M$?\ @I9_R&O '_7&\_\ 0HJ]W(_]_A\_R9\IQ3_R*:O_ &[_ .E(^P/@_P#\
MDF\%?]@6R_\ 1"5UU<C\'_\ DDW@K_L"V7_HA*ZZO'K?Q)>K/H\-_ AZ+\@H
MHHK(Z#P[]K[XS7/P;^%,L^ER^3KVJR_8;*4=8<J2\H]U48'HS*:^;?V1_P!D
MRP^*NEOXZ\=&XO--N)W%G8^:RF[96(>61P=VW=D8!!)!R<=>J_X*6VURVG>!
M+@9-HLEXC>@<B$C] ?R-?07[*U]::A^SWX(DLF5HTL!$^WM(C,LGX[@WYU]3
M&I+!Y7&I1TE-ZOKU_P OS/@IT89EGTZ.*5X4HIJ+V;=M;?/\BMKW[)/PGU_2
MWL7\'V=CD86XL2T,R'L0P/)_WLCVKG?V=_V1].^!'BG6M<.KS:O<S9M[#(,8
MBMS@GS #AG)&,] %R.N!]!45XGU[$^SE2<VXO>^I]1_9>"]M"NJ24H[-*WY;
M^5]@HHHKA/5"BBLGQ9XFLO!?AC5==U%_+L=.MI+F8]]JJ3@>YZ >I%.*<FDM
MR924(N4G9(^*/V_/']UXN\:^&_AAHI:XECDCGN88SS)=2_+#']0K9_[:CTK@
M/"=M>?L;_M36&GZA=F;2)4C@N;HC:LUK.HS)CT1QGZQ&J/[/_P 0_#&K?M#:
ME\1?B/K<.F^7)+?0))%+*'N'.$4!%.%122,]-J5W/[;?Q&^&?Q<\/Z+J_ACQ
M+!?^(M,E,+0+;3QM+;OSU9 ,JP! ST=J_0J=.5!PR]P;@XM2=M+OS\OU\C\<
MK588N-7-U52JJ:<(MJ_+'2UK]?QMYGZ *P900<@\@BEKP_\ 8\^*G_"T/@MI
M9N9O,U;1_P#B6WFXY9M@'EN?7<FW)[L&KW"O@Z]&6'JRI3W3L?K>%Q$,70A7
MI[25PHHHK ZBOJ'_ "#[G_KDW\C7YX_\$[?^2X:[_P!@.;_T?!7Z':A_R#[G
M_KDW\C7YX_\ !.W_ )+AKO\ V YO_1\%?19?_N6*]%^I\7G/_(TP'K+]#]%J
M***^=/M HHHH *_.O_@H1K-U??&O1=)OKB2+2+738GC11D+YDC^8X'<G:!_P
M 5^BE>/?M#?LTZ#^T!IML;NXDTK7+)62TU*% ^%/.R1,C<N>>H().#R0?7RO
M$T\+B54J[:KT\SYW/L#6S# RHT/BNG;O;H5?"'[-_P %=8\'6/\ 9'AO2-;T
MN6%?+U$.9991C[QE!W GN 1@]A6=\-_V-O!GPP^*#>+]*EN98HHB++3;H[UM
M93P7#]6^7( ;)&2<DXQ\P:A^R%\;_A'<RWO@_4WO8T.[S-"U!H)6 _O(Q0D^
MPW5V/[/?[8WB_3O'UEX&^)<;7!N+E;%;RX@\F[M9F.U5E&!N4D@'(!&<Y/2O
M7J8?$RISGA<1[2+6JOK;T_X8^=HXW!1K4J>/P7L9IKE=O=OZJWZI;^9]U444
M5\B?H@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5^;7_!0OP[+I?QMMM3*?Z/J>F0R*_JZ%HV'X!5/XU^DM>,
M_M*_LZVW[06DZ#;F]73+S3;S?]J*;C]G? F0#^\=J$9XROO7L95BHX3%*=1V
MB[I_UZGS?$& J9A@)4J2O)--?UZ-GY[?L^?L^:Y\>O%(M+,-9:):LK:AJC+E
M(5_NK_><]E_$X K]3? '@#1/AEX5L_#_ (?LULM.M5X'5Y&/WI';^)CW/X<
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M>TVWU73G97:VNDW(6'0X]J;X4\&Z)X%TG^S/#^F6^D:?O,OV>U3:FXXR<>O
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MQD<'3J.*?M)*R?9'SV99;/,JU%5&O90=VN[Z?+_-GB'_  [^^%?IK7_@:O\
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ML#7D0<QAL;L?7 _*O1R_%1P>)C6FKI7_ "/&SC SS+!3PU-I-VW\FF0_!_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140100121314240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 13,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CENTESSA PHARMACEUTICALS PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3rd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">1 Ashley Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Altrincham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cheshire<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">WA14 2DT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">+44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">7391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">789784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001847903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1612294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, nominal value &#163;0.002 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember', window );">American Depositary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>cnta-20231113_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cnta="http://www.cnta.com/20231113"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cnta-20231113.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cnta:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-28">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001847903</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-11-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CENTESSA PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-40445</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">98-1612294</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3rd Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">1 Ashley Road</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="c-1" id="f-9">Altrincham</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Cheshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">WA14 2DT</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c-1" id="f-12">GB</dei:EntityAddressCountry>
    <dei:CountryRegion contextRef="c-1" id="f-13">+44</dei:CountryRegion>
    <dei:CityAreaCode contextRef="c-1" id="f-14">7391</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">789784</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-20">Ordinary shares, nominal value &#xa3;0.002 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-21">CNTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-22">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-23">American Depositary Shares, each representing one ordinary share, nominal value &#xa3;0.002 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-24">CNTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-25">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-27">false</dei:EntityExTransitionPeriod>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-30">2023-11-13</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MLN(PX0R6C^X&^'VAE'TY<=N^Y:[]X#]02P,$%     @ (()M5Y^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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MH'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @
M(()M5R0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ (()M5P=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  @@FU7]38Y
MP^X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  @@FU7F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( """;5>^;F:), 4  ,$7
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  @@FU7GZ ;\+$"  #B#   #0              @ %S#0
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( """;5>7BKL<P    !,"   +
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4!08     "0 ) #X"  #'%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cnta-20231113.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cnta.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="cnta-20231113.htm">cnta-20231113.htm</File>
    <File>cnta-20231113.xsd</File>
    <File>cnta-20231113_def.xml</File>
    <File>cnta-20231113_lab.xml</File>
    <File>cnta-20231113_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cnta-20231113.htm": {
   "nsprefix": "cnta",
   "nsuri": "http://www.cnta.com/20231113",
   "dts": {
    "inline": {
     "local": [
      "cnta-20231113.htm"
     ]
    },
    "schema": {
     "local": [
      "cnta-20231113.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "cnta-20231113_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cnta-20231113_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnta-20231113_pre.xml"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 33,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 30
   },
   "report": {
    "R1": {
     "role": "http://www.cnta.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cnta-20231113.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cnta-20231113.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "cnta_AmericanDepositarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.cnta.com/20231113",
     "localname": "AmericanDepositarySharesMember",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "American Depositary Shares",
        "label": "American Depositary Shares [Member]",
        "documentation": "American Depositary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Three",
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country Region",
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001847903-23-000187-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001847903-23-000187-xbrl.zip
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M?OGE-.9QP.HH6GHN5J>%],O30@JZ%WF3^JG'[XB,)P$[TSPN1P&=U,(H9+
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MG0H^4Y):SI$JD#UN,MX2W]^OY\P[9!1R1K'VA#-]Q%^:Z"VU1[W!-$1/R8+
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MB3-18L;/C=):LNWD8FUF]:3W"U!+ P04    "  @@FU7ZJD&*\H(  #D00
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M5P#J_G>WAM))807+KH,5!--R1FR$@A3*L^2TM9Z[26A\R^HH,L3.D#%9V*T
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M+7/C=H7M3J7SX5IN24AX>1%.7'T,PZZEY)+GD5)BG*9$%H4A-L2"%"Y <H7
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MJU4.]0ZU\J?YI.\%)7TI25O[$Y.^Y]FY\)'.-9?!>\A"O&A5+0#/2M=?2#G
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MX%JY?/[-\;49FT,MG4$H18SII8V#8M* %EQH<L28G$X37]64[^@KYSWD^0E
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MWKB$'X;*G<%?DWCJO?M_4$L! A0#%     @ (()M5\6T]V^:$   5W0  !$
M             ( !     &-N=&$M,C R,S$Q,3,N:'1M4$L! A0#%     @
M(()M5\D&"L,E P  L0H  !$              ( !R1   &-N=&$M,C R,S$Q
M,3,N>'-D4$L! A0#%     @ (()M5^JI!BO*"   Y$$  !4
M ( !'10  &-N=&$M,C R,S$Q,3-?9&5F+GAM;%!+ 0(4 Q0    ( """;5<D
M<$M2^0T  !J%   5              "  1H=  !C;G1A+3(P,C,Q,3$S7VQA
M8BYX;6Q02P$"% ,4    "  @@FU7RLS16:L(  !C1P  %0
M@ %&*P  8VYT82TR,#(S,3$Q,U]P<F4N>&UL4$L! A0#%     @ (()M5\()
MJ_C](   OVD! !$              ( !)#0  &-N=&%P<BUQ,S(P,C,N:'1M
64$L%!@     &  8 A@$  %!5      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
